Safety Partnership Organisations
The Medicines and Healthcare Products Regulatory Agency regulates medicines and medical devices in the UK.
Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development.
The agency has 3 centres:
- the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s regulator of medicines, medical devices and blood components for transfusion, responsible for ensuring their safety, quality and effectiveness
- the Clinical Practice Research Datalink (CPRD), a data research service that aims to improve public health by using anonymised NHS clinical data
- the National Institute for Biological Standards and Control (NIBSC), a global leader in the standardisation and control of biological medicines
|Patient Safety Domain of NHS England|
The Patient Safety Domain of NHS England has a system leadership role for patient safety in the NHS and in particular supports the NHS to identify, understand and manage risks to the safety of patients, not least via routine review of patient safety incident reports sent to the National Reporting and Learning System (NRLS).
A major part of the domain’s work is alerting the NHS to emerging patient safety risks through timely dissemination of relevant safety information to providers, including information on how to reduce and avoid risk.
Following the tragic events at Mid Staffordshire NHS Foundation Trust, the Patient Safety Domain has played a key role in taking forward the recommendations of the Francis Report, Berwick Report and Hard Truths, which set out the government’s official response to the Francis Report.
A range of initiatives are underway to change the safety culture in the NHS to being one that is more open and honest, so we can learn from when things go wrong and take steps to prevent them from being repeated. These initiatives will ensure continual learning around safety improvement sits at the heart of the NHS, that the spread of successful safety improvement best practice can be accelerated across the country, and that we are open and transparent through the publishing of patient safety data.
These initiatives include:
- Launching a new National Patient Safety Alerting System (NaPSAS)
- The monthly publishing of data on never events
- Publishing of key patient safety indicators by hospital on My NHS (NHS Choices)
- Launching the Patient Safety Collaboratives
- Developing the Q initiative with the Health Foundation to connect people from across the UK who are skilled in safety and quality improvement
Barema - the Association of Anaesthetic and Respiratory Device Suppliers - brings together companies that manufacture or supply anaesthetic and respiratory equipment in or to the UK. With a membership of over 50 companies, Barema represents around 70% of the anaesthetic and respiratory medtech sector. Chief amongst Barema's objectives is maintaining the sector's reputation for exceptionally high levels of safety, quality, reliability and innovation. The continuous development and refinement of medical devices in anaesthesia underpins enhanced patient care and improved patient safety.
Meeting this objective is critically dependent on Barema working with clinical bodies such as the AAGBI. To facilitate direct dialogue between suppliers and the anaesthetic profession, AAGBI and Barema have:
- a working relationship stretching back to 1971
- twice-yearly meetings of the AAGBI Executive with Barema Council members
- permanent representation of Barema on AAGBI Safety Committee
- regular two-way communications
- industry engagement sessions at AAGBI meetings
Barema thus enables manufacturers to both respond to and have input on safety issues and changing demands in patient care. For more information see www.barema.org.uk or email Dr Anne Cooke at firstname.lastname@example.org
The role of NCEPOD (National confidential Enquiry into Patient Outcome and Death) is to assist in maintaining and improving standards of health care by reviewing the management of patients, through the use of national, topic based anonymised case note review and assessment of Trust organisational data. This facilitates an assessment of the quality of care and service delivery for patients at both local and national level. The results are published and made available in the public domain. Reports identify key messages and recommended actions for improvement relating to the topic area covered.
For more information see http://www.ncepod.org.uk/